Clover Health Investments Corp. [NASDAQ: CLOV] loss -5.03% or -0.62 points to close at $11.71 with a heavy trading volume of 30911900 shares. The company report on June 24, 2021 that Clover Plans Expansion into 101 New Markets.
Expansion nearly doubles company’s geographic footprint based on number of counties.
, Clover Health (NASDAQ: CLOV) (“Clover”), an innovative technology company committed to improving health equity for America’s underserved seniors, announces plans to nearly double its geographic footprint. The expansion, which is subject to CMS approval, will make Clover’s Medicare Advantage (MA) plans available to eligible individuals in a total of 209 counties across nine states.
It opened the trading session at $12.164, the shares rose to $12.20 and dropped to $11.30, the range by which the price of stock traded the whole day. The daily chart for CLOV points out that the company has recorded -30.17% loss over the past six months. However, it is still -85.58% lower than its most recent low trading price.
If we look at the average trading volume of 58.26M shares, CLOV reached to a volume of 30911900 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Clover Health Investments Corp. [CLOV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $9.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 3.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on June 10, 2021. While these analysts kept the previous recommendation, BofA Securities raised their target price from $15 to $9. The new note on the price target was released on May 17, 2021, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $10, while Credit Suisse analysts kept a Neutral rating on CLOV stock.
The Average True Range (ATR) for Clover Health Investments Corp. is set at 2.00, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 25.12. The Price to Book ratio for the last quarter was 7.51, with the Price to Cash per share for the same quarter was set at 1.59.
Trading performance analysis for CLOV stock
Clover Health Investments Corp. [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.71. With this latest performance, CLOV shares gained by 30.98% in over the last four-week period, additionally sinking by -30.17% over the last 6 months – not to mention a rise of 7.93% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 48.44, with the RSI for the last a single of trading hit 43.47, and the three-weeks RSI is set at 50.54 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 10.42, while it was recorded at 12.70 for the last single week of trading, and 10.83 for the last 200 days.
Clover Health Investments Corp. [CLOV]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp. [CLOV] shares currently have an operating margin of -5752.28. Clover Health Investments Corp.’s Net Margin is presently recorded at -5752.28.
Return on Total Capital for CLOV is now -1.70, given the latest momentum, and Return on Invested Capital for the company is -1.70. Return on Equity for this stock declined to -1.70, with Return on Assets sitting at -1.57. When it comes to the capital structure of this company, Clover Health Investments Corp. [CLOV] has a Total Debt to Total Equity ratio set at 0.10. Additionally, CLOV Total Debt to Total Capital is recorded at 0.10, with Total Debt to Total Assets ending up at 0.09.
Reflecting on the efficiency of the workforce at the company, Clover Health Investments Corp. [CLOV] managed to generate an average of -$14,727 per employee.Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.70 and a Current Ratio set at 4.70.
Clover Health Investments Corp. [CLOV]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 32.00%.
An analysis of insider ownership at Clover Health Investments Corp. [CLOV]
There are presently around $1,825 million, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: GREENOAKS CAPITAL PARTNERS LLC with ownership of 96,331,338, which is approximately New of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 26,185,529 shares of the stock with an approximate value of $306.63 million in CLOV stocks shares; and BAILLIE GIFFORD & CO, currently with $60.22 million in CLOV stock with ownership of nearly New of the company’s market capitalization.
Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of September and at the time of the September reporting period, where 109 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 150,607,965 shares. Additionally, 62 investors decreased positions by around 12,653,849 shares, while 12 investors held positions by with 7,371,756 shares. The mentioned changes placed institutional holdings at 155,890,058 shares, according to the latest SEC report filing. CLOV stock had 91 new institutional investments in for a total of 148,647,212 shares, while 49 institutional investors sold positions of 9,687,852 shares during the same period.